TLPH — TALPHERA, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1427925 ·
Last close
$0.87
Market Cap
$45.15M
52W High
$0.99
52W Low
$0.69
ADV30
148,133
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -3,948,000 | -2,556,000 | 30,155,000 | 3,823,000 | 11,677,000 |
| Dec 2025 | 0 | — | -3,453,000 | -3,772,000 | 29,719,000 | 5,894,000 | 12,684,000 |
| Sep 2025 | 1,000 | — | -3,422,000 | -4,436,000 | 30,742,000 | 3,457,000 | 11,565,000 |
| Jun 2025 | 0 | — | -3,693,000 | -3,489,000 | 16,515,000 | 6,791,000 | 9,888,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,294,000
Investing CF
$-17,059,000
Financing CF
$26,788,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.31
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-474,076,000
Inventory
—
Receivables
—
ST Investments
$17,285,000
EBIT TTM
$-15,645,000
Pretax Income TTM
$-14,253,000
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,000
EBITDA
—
Free Cash Flow
$-5,777,500
Enterprise Value
$30,720,152
Total Cash
$21,108,000
Total Debt
$6,499,000
Shares Out
51,899,648
Trailing EPS
$-0.28
Book Value
$0.34
ROE
-118.4%
ROA
-40.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,000 | -13,484,000 | -14,290,000 | 29,719,000 | 12,684,000 | — | -11,364,000 |
| Dec 2024 | 0 | -15,252,000 | -13,004,000 | 18,236,000 | 10,235,000 | — | -12,683,000 |
| Dec 2023 | 651,000 | -16,889,000 | -18,397,000 | 20,395,000 | 6,290,000 | — | -17,492,000 |
| Dec 2022 | 0 | -20,352,000 | 47,755,000 | 47,487,000 | 25,673,000 | — | -28,331,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.27
Max Pain — expiry 2026-12-18
max pain strike: $1.00 · spot: $0.89 · call oi: 3,051 · put oi: 542
Expected Move to 2026-12-18:
±$1.12
(127.08%) —
implied range
$-0.24 –
$2.01
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IXHL | Incannex Healthcare Inc. | $45.82M | $3.83 | — |
| VICP | Vicapsys Life Sciences, Inc. | $47.26M | $1.46 | — |
| INCR | Intercure Ltd. | $47.79M | $0.87 | — |
| PYRGF | PyroGenesis Canada Inc. | $42.61M | $0.19 | — |
| VERU | VERU INC. | $48.15M | $3.00 | — |
News headlines (Yahoo Finance, 1h cache)
Talphera, Inc. Q1 2026 Earnings Call Summary
2026-05-14 12:30 · Yahoo
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ...
2026-05-14 05:02 · Yahoo
Talphera Q1 2026 Earnings Call Transcript
2026-05-13 21:40 · Yahoo
Talphera (TLPH) Q1 2026 Earnings Transcript
2026-05-13 21:37 · Yahoo
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-13 20:05 · Yahoo
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
2026-05-07 20:05 · Yahoo
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
2026-03-25 12:30 · Yahoo
Talphera: Q4 Earnings Snapshot
2026-03-23 12:44 · Yahoo
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2026-03-23 12:30 · Yahoo
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
2026-03-18 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.